Results 221 to 230 of about 136,011 (340)
Stereotactic body radiotherapy (SBRT) and bevacizumab are used in the treatment of colorectal liver metastases. This study prospectively evaluated changes in perfusion of liver metastases in seven patients treated with both bevacizumab and SBRT ...
Jay S. Detsky+6 more
doaj
Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia [PDF]
Izumi Yamamoto+4 more
openalex +1 more source
Abstract The incidence of juvenile‐onset recurrent respiratory papillomatosis (JORRP) varies worldwide, and the lack of well‐adopted guidelines for use in China suggests that patients with JORRP do not receive optimal care. In America, where data are available, pediatric patients undergo an average of 4 surgeries annually and a total of >40 surgeries ...
Working Group of Chinese Guideline for the Diagnosis and Treatment of JORRP+57 more
wiley +1 more source
Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma [PDF]
Jason D. Wright+7 more
openalex +1 more source
Healthcare Disparities in the Treatment and Outcomes of Hepatocellular Carcinoma in South Africa
ABSTRACT Background The impact of healthcare disparities on the outcomes for hepatocellular carcinoma (HCC) has not been explored in South Africa. This study aims to evaluate and compare the presentation, treatment, and outcomes of HCC in a cohort of patients treated in the public and private sectors.
Sanju Sobnach+10 more
wiley +1 more source
Objective The clinical benefits of neoadjuvant bevacizumab plus chemotherapy in locally advanced gastric cancer patients are controversial. This study intended to evaluate the efficacy and safety of neoadjuvant bevacizumab plus chemotherapy in these ...
Bin Yin, Wei Luo
doaj +1 more source
Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy [PDF]
Brian I. Rini+5 more
openalex +1 more source
ABSTRACT Differentiating between radiation necrosis and true tumour progression after radiotherapy is challenging due to overlapping imaging appearances. This review outlines useful techniques and imaging features for making this distinction, as well as potential pitfalls.
Arian Lasocki+2 more
wiley +1 more source